Latest News

View allAccessAL amyloidosisCAR-TConferencesMPEMyelomaNewsPatient evidenceVideos

Myeloma Patients Europe (MPE) holds first Myeloma CAB

  In addition to providing education, information and support to its 46 member-groups across 30 European countries, Myeloma Patients Europe (MPE) advocates for the best possible research and equal access to the most innovative treatment and care. With this aim, MPE has developed a series of Community Advisory Boards (CABs) focused on myeloma.

Read more

Takeda announces discontinuation of the phase 3 clinical trial TOURMALINE-AL1 in AL amyloidosis

  The pharmaceutical company Takeda announced that the Phase 3 TOURMALINE-AL1 clinical trial in patients with relapsed or refractory AL amyloidosis did not meet the first of two primary endpoints. Treatment with ixazomib in combination with dexamethasone did not demonstrate a significant improvement in overall hematologic response compared to physician’s choice of standard of care…

Read more

Lenalidomide and pomalidomide based triplet combination regimens for myeloma patients receives approval from the European Commission

The European Commission has approved two of Celgene’s IMiD ® -based combination regimens: Lenalidomide (Revlimid®) in combination with bortezomib and dexamethasone (RVd) in adult patients with previously untreated multiple myeloma who are not eligible for transplant Pomalidomide (Imnovid®) in combination with bortezomib and dexamethasone (PVd), in adult patients with multiple myeloma, who have received at…

Read more

In Memoriam of Peter Lens

  It is with great sadness that we share that our friend and colleague, Peter Lens, has passed away. Peter was a myeloma patient and member of the first Board of Myeloma Patients Europe (MPE). He was always very passionate and supportive of MPE, its Board and staff.

Read more

Results of MPE members participation in EMA survey on bortezomib

As bortezomib, an anti-myeloma medicine, is licensed as both an intravenous (IV – through the vein via a drip) and subcutaneous medicine (through the skin, via an injection), the European Medicines Agency (EMA) recently conducted a survey to understand which method was most commonly used across Europe. They also asked about the location of administration…

Read more
April

May 2026

June
MO
TU
WE
TH
FR
SA
SU
27
28
29
30
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
Events for 1st May
No Events
Events for 2nd May
No Events
Events for 3rd May
No Events
Events for 4th May
No Events
Events for 5th May
No Events
Events for 6th May
No Events
Events for 7th May
No Events
Events for 8th May
No Events
Events for 9th May
No Events
Events for 10th May
No Events
Events for 11th May
No Events
Events for 12th May
No Events
Events for 13th May
No Events
Events for 14th May
No Events
Events for 15th May
No Events
Events for 16th May
No Events
Events for 17th May
No Events
Events for 18th May
No Events
Events for 19th May
No Events
Events for 20th May
No Events
Events for 21st May
No Events
Events for 22nd May
No Events
Events for 23rd May
No Events
Events for 24th May
No Events
Events for 25th May
No Events
Events for 26th May
No Events
Events for 27th May
No Events
Events for 28th May
No Events
Events for 29th May
No Events
Events for 30th May
No Events
Events for 31st May
No Events